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Case Report
Hyperglycemia Followed by an Abrupt Decrease
of Blood Glucose Is a Rare Cause of Posterior
Reversible Encephalopathy Syndrome (PRES)
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Introduction

Posterior Reversible Encephalopathic Syndrome (PRES) is a clinical syndrome of headache,
confusion or decreased level of consciousness, visual changes, seizures and focal neurologic
signs associated with characteristic neuroimaging findings of posterior cerebral white matter edema. In most cases, PRES is precipitated by sudden increase in blood pressure; however, in the case presented here, the etiology was different as it was secondary to extreme
changes in glucose levels.
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Case Presentation

A 49-year-old female with a past medical history of hypertension and diabetes mellitus,
type 2 was brought to the emergency room with a chief complaint of visual changes for
1 hour in duration. She described that the visual changes, like blurred vision in both eyes,
happened after an abrupt decrease of blood glucose (BG) from 700 to 75 mg/dl. This abrupt
drop in BG led to PRES in this patient, which is an uncommon presentation. Magnetic resonance imaging (MRI) of the brain was obtained, which was consistent with demyelinating
lesions present in bilateral occipital lobes, suggestive of PRES. Fortunately, the patient’s
symptoms improved after avoidance of further abrupt fluctuations in BG. PRES commonly
resolves within days if diagnosed and treated early. Prompt management can reduce morbidity and mortality.

Conclusion

A diagnosis of PRES can be difficult, especially if it was caused by rare etiology. In this case
we highlight the cause and explain the hypothesis behind it.
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Introduction

Posterior reversible encephalopathy syndrome
(PRES) was first described in 1996 by Hinchey
et al. This condition has been previously known
by various names including reversible posterior leukoencephalopathy syndrome, reversible
posterior cerebral edema syndrome and reversible occipital parietal encephalopathy.1 PRES is
a clinical-radiological diagnosis characterized by
varying neurological manifestations including
headache, vision changes, confusion, focal neu-

rological deficits and seizure with classic brain
magnetic resonance imaging (MRI) consistent
with edema of the white matter of the bilateral
posterior cerebral hemispheres, mostly in the
parieto-occipital lobes. The most common entities associated with PRES include uncontrolled
hypertension, pre-eclampsia/eclampsia, cancer
chemotherapy, renal insufficiency, autoimmune disease, systematic lupus erythematosus
(SLE), immunosuppression therapy and sepsis. More than 70% of patients with PRES are
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hypertensive, though a significant proportion
have normal or only mildly raised blood pressure (BP).2-6
The case presented is unique as PRES was
precipitated by an episode of hyperglycemia
followed by rapid drop of blood glucose (BG).
A proposed mechanism for this very rare and
unusual etiology is considered in the discussion.

Case Presentation

A 49-year-old female with hypertension and
diabetes mellitus, type 2 presented to the
emergency department complaining of sudden, painless, non-traumatic vision changes in
both eyes along with some flashes. Her symptoms began on the same morning after a rapid
correction of BG by insulin administration.
She stated that her BG readings were always
within an acceptable range, except the night
before presentation when she noticed that her
BG was 900 mg/dl due to being out of insulin
for about 2 days. Her high BG reading led to
administration of both short and long acting
insulin. Repeated BG was 500 mg/dl at bedtime, around 10:00 PM. The following morning
at 7:00 AM she woke up with BG of 700 mg/
dl without any symptoms. At that point she increased her short acting insulin dose to 25 units
instead of 5 units (5 times her normal dose), which
caused an abrupt drop of BG to 75 mg/dl one and

Figure 1. The axial CT of the brain shows fairly
symmetric subcortical hypodensity involving
a posterior predominant pattern highly suspicious for PRES.
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Figure 2. The MRI of the brain with axial T2
shows fairly symmetric subcortical area in a
posterior predominant pattern including parietal lobes.
a half hours after insulin administration. Shortly after that she started having blurred vision
that caused her to present to the emergency
department.
On arrival to the emergency department, her
BP was 135/85, which was consistent with her
typical BP at home. On neurological exam she
was alert and oriented with normal speech.
Visual acuity was 20/40 and visual field testing,
performed clinically by counting the metric
digit in all fields, and her examination showed
that she had bi-temporal vision loss. The rest
of the clinical exam was unremarkable including
normal pupillary and corneal reflexes, no motor
or sensory deficits, normal gait, cranial nerves
II-XII intact and no meningeal irritation signs.
During hospitalization, her BG readings were
85-120 mg/dl, hemoglobin A1C (HbA1c) was
5.6%, and both liver and kidney function were
normal. On admission, computerized tomography (CT) of the brain (Figure 1) was obtained and showed bilateral, fairly symmetric
subcortical hypodensities involving parietal
and occipital lobes suspicious for PRES. Brain
MRI Axial T2 with and without contrast (Figure 2) showed fairly symmetric subcortical
hyperintensities in the parietal and occipital
lobes. Brain MRI T2 fluid-attenuated inversion
recovery (FLAIR) with and without contrast
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and seizures. Usually it occurs in the setting of
hereditary or acquired thrombophilia. Brain MRI
in CVT usually presents with focal or multifocal
areas of edema and venous infarction that are
usually distinguishable from PRES.

Discussion

PRES is usually diagnosed by clinical features
and radiographic imaging such as a brain MRI.
Clinical features may vary and include headache, altered mental status, visual disturbance
and seizures.10 PRES is most commonly caused
by the sudden elevation of BP. Other causes
include, but are not limited to, renal insufficiency, autoimmune disease, systemic lupus erythematosus, immunosuppression therapy and
sepsis.2,11,12 PRES is a reversible syndrome if it is
diagnosed early and treated promptly.
Figure 3. The T2 FLAIR of the brain shows fairly
symmetric subcortical area in a posterior predominant pattern including parietal lobes.
(Figure 3) showed fairly symmetric subcortical
hyperintensities in the parietal and occipital
lobes, while diffusion-weighted imaging (DWI)
of the brain (Figure 4) appeared to show clear
restricted diffusion. Computed tomography
angiography (CTA) and magnetic resonance
angiography (MRA) were negative. Lumbar
puncture was performed and did not reveal any
signs of infection, elevation in immunoglobulin
G (IgG) index or oligoclonal bands. Her clinical
symptoms and brain MRI findings suggested
the possibility of PRES. The patient’s vision
gradually improved during the hospitalization
as her BG levels were controlled, and BG was
completely back to normal by the next day
when she was discharged home.
It is important to differentiate PRES from
other diseases. Differential diagnoses are
osmotic demyelination syndrome (ODS), as an
initial presentation of hyperosmolar hyperglycemia state, and cerebral venous thrombosis
(CVT). ODS in the setting of hyperosmolar
hyperglycemia state usually presents as altered
mental status, dyspnea, dysarthria and dysphagia, which all occur 5 to 7 days after the rapid
correction of severe hyponatremia,7,8,9 while in
PRES the presentation will be within hours.
The other differential diagnosis is CVT. The
clinical presentation of CVT is highly variable
but often presents with headache, confusion

The pathogenesis behind PRES remains unclear. However, we believe that PRES is caused
by a failure of cerebral autoregulation, which
usually occurs after a sudden rise of BP, and/or
endothelial dysfunction of the blood‐brain barrier (BBB) that can play a role in the pathogenesis by breaking down the BBB, which allows
for hematogenous products to diffuse slowly
over time into the brain cells, resulting in areas
of edema.13-15 Sudden increase in BP will lead
to hyperperfusion of the brain, consequently
causing extravasation of fluid and blood into
the brain parenchyma.16

Figure 4. On the MRI of the brain with diffusion-weighted imaging (DWI) there is clear
restricted diffusion.
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The etiology of PRES in this case was unusual as it was likely caused by high BG followed
by an abrupt drop in BG.17 The underlying
pathogenesis of PRES in hyperglycemia in the
absence of ketoacidosis and other metabolic
disorders is not fully understood. However, it is
thought to be caused by endothelial dysfunction caused by excessive circulating inflammatory cytokines.18 Hyperglycemia is associated
with increased pro-inflammatory cytokines including interleukin 6 and tumor necrosis factor
(TNF) alpha, which has been shown to regulate
vascular endothelial growth factor (VEGF).
VEGF will lead to increased vascular permeability and eventually vasogenic edema.19 Vasogenic
edema is an extracellular accumulation of fluid
resulting from the disruption of the BBB and
extravasation of serum protein.20 The excessive
extracellular accumulation of fluid leads to an
increase of brain volume and intracerebral pressure. There has been one case report of PRES
caused by hyperglycemia without any metabolic derangement, and the patient presented
with reversible blindness.17 The patient was a
28-year-old non-pregnant female with type 1
diabetes mellitus on basal bolus insulin, who
presented with headache and blurred vision for
2 hours, after missing doses of insulin in the
previous 2 days. On physical exam her BP was
normal. Her BG was high with no ketone in the
urine. She was managed for hyperglycemia and
her vision recovered in 5 days.17
In our patient we hypothesize that the sudden
drop in BG may also have precipitated PRES.
We believe this is due to the sudden change
in osmolality resulting in transient osmotic
gradient between plasma and neuroglial cells.
This gradient will result in a fluid shift into neurons and cause cerebral edema. PRES is likely
more evident in the posterior brain region due
to diminished sympathetic innervation of the
vertebro-vascular system.21,22
As primary care physicians and hospitalists,
it is important to identify complications such
as PRES, which are reversible and associated
with excellent prognosis if diagnosed early and
treated promptly. Early diagnosis and treatment of the inciting cause are imperative to
reduce the neurological sequalae, morbidity
and mortality.
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Conclusion

PRES most often occurs in the setting of hypertensive crisis, pre-eclampsia or with cytotoxic immunosuppressive therapy. However, in
our case, PRES was secondary to blood glucose
fluctuations. After an extensive workup, we can
conclude that this patient’s symptoms, imaging findings and cerebrospinal fluid testing are
consistent with PRES and that stabilizing the
patient’s BG level helped to resolve the symptoms. Therefore, early diagnosis is a crucial
point in the case of PRES.
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